HAE News and Press, Haemonetics Corporation

2024-06-21 15:50:11 ET Summary Haemonetics faces near-term revenue growth challenges due to the loss of its plasma collections business with CSL over the next two years. Management has used M&A to boost its revenue growth, including the very successful deal for Cardiva to ente...

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device PR Newswire BOSTON , June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions ...

2024-06-12 07:15:07 ET Needham analyst issues BUY recommendation for HAE on June 12, 2024 05:38AM ET. The previous analyst recommendation was Hold. HAE was trading at $83.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst ...

2024-06-12 07:00:12 ET Mike Matson from Needham issued a price target of $112.00 for HAE on 2024-06-12 05:20:00. The adjusted price target was set to $112.00. At the time of the announcement, HAE was trading at $83.41. HAE currently trades -14.88% versus its 52 week high...

2024-06-08 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-23 06:18:45 ET More on Haemonetics Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript Haemonetics Corporation: Improved Performance, Another Bolt-On Deal Haemonetics to buy Attune Medical for $160M Seeking Alpha’s Quant Rating on Ha...

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes PR Newswire BOSTON , May 23, 2024 /PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $600,000,000 aggregate p...

2024-05-21 16:10:26 ET More on Haemonetics Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript Haemonetics Corporation: Improved Performance, Another Bolt-On Deal Haemonetics Q4 2024 Earnings Preview Haemonetics to buy Attune Medical for $160M ...

2024-05-18 08:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-10 00:25:23 ET Haemonetics Corporation (HAE) Q4 2024 Earnings Conference Call May 09, 2024 08:00 AM ET Company Participants Olga Guyette - Senior Director of Investor Relations and Treasury Christopher Simon - President and Chief Executive Officer James D...